32 studies found for:    " February 02, 2007":" March 02, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Study of Pharmacokinetics in HIV-infected Women
Condition: HIV Infections
Intervention: Drug: antiretroviral treatment
22 Unknown  A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor
Condition: HIV Infections
Intervention:
23 Completed Lopinavir Capsules to Kaletra or Invirase Tablets
Condition: HIV Infections
Interventions: Drug: Saquinavir (Invirase®);   Drug: Lopinavir/ritonavir (Kaletra®)
24 Completed Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients
Condition: HIV Infection
Intervention:
25 Completed Pharmacogenetics of Antiretroviral Drugs
Condition: HIV Infections
Intervention:
26 Completed Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Conditions: Epidemic Kaposi's Sarcoma;   Recurrent Kaposi's Sarcoma
Intervention: Drug: interleukin-12
27 Completed A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701
Condition: HIV Infection
Intervention: Drug: No Intervention -- Observational study
28 Terminated
Has Results
MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)
Condition: HIV Infection
Interventions: Drug: MK0518 (raltegravir);   Drug: Comparator: KALETRA™ (lopinavir (+) ritonavir );   Drug: Comparator: placebo
29 Terminated
Has Results
MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)
Condition: HIV Infection
Interventions: Drug: Comparator: raltegravir;   Drug: Comparator: placebo;   Drug: Comparator: lopinavir (+) ritonavir
30 Completed
Has Results
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
Condition: HIV Infections
Interventions: Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate
31 Terminated
Has Results
SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir;   Drug: Optimized Background Regimen (OBR)
32 Completed Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications
Condition: HIV Infections
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page   
Indicates status has not been verified in more than two years